Inventor

Marc Mercken

Inventor
Turnhout, BE

Overview

21→
Patents
1998–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
A61KPreparations for medical, dental or toiletry purposes13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%
C07DHeterocyclic compounds5%
A01KAnimal husbandry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C12NMicroorganisms or enzymes2%
PatentTitleYear
10,851,156Methods of detecting pyroglutamate amyloid beta protein (3pE Ab) using anti-3pE Ab antibodies202010,766,953Anti-PHF-tau antibodies and uses thereof202010,633,435Anti-PHF-tau antibodies and uses thereof202010,519,223Antibodies to pyroglutamate amyloid-b and uses thereof201910,196,440Anti-PHG-tau antibodies and their uses201910,000,559Anti-PHF-tau antibodies and their uses20189,939,452N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses20189,745,371'Anti-PHF-tau antibodies and their uses'20179,371,376'Anti-PHF-tau antibodies and their uses'20169,329,189'N-11 truncated amyloid-beta Aβ11-x monoclonal antibodies and compositions'20168,911,731'Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof'20148,461,145'Dibenzoazepine and dibenzooxazepine TRPA1 agonists'20138,383,637'2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)'20138,163,873'Isolated microtubule-associated protein tau peptides and kit'20127,183,288'Amide derivatives as glycogen synthase kinase 3-β inhibitors'20076,900,293'Monoclonal antibodies directed against the microtubule-associated protein tau'20056,238,892'Monoclonal antibodies directed against the microtubule-associated protein tau'20016,232,437'Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.'20016,010,913'Isolated human tau peptide'20005,861,257'Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications'19995,843,779'Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2012Patents assigned to INNOGENETICS NV (7)· patent assignee history
1998–2005Based in Somerville, MA, US· patent location history
1999Based in Tokyo, JP· patent location history
2001Based in Sommerville, MA, US· patent location history
2007–2016Patents assigned to MERCKEN MARC HUBERT (5)· patent assignee history
2007Patents assigned to ARTS THEODORA JOANNA FRANCISCA (1)· patent assignee history
2007–2019Based in Beerse, BE· patent location history
2012–2020Based in Turnhout, BE· patent location history
2013–2020Patents assigned to JANSSEN PHARMACEUTICA NV (7)· patent assignee history
2016–2020Patents assigned to JANSSEN BIOTECH INC (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INNOGENETICS NV71998–2012
JANSSEN PHARMACEUTICA NV72013–2020
JANSSEN BIOTECH INC52016–2020
MERCKEN MARC HUBERTself52007–2016
ARTS THEODORA JOANNA FRANCISCA12007
Locations
LocationPatentsSpan
Turnhout, BE92012–2020
Beerse, BE62007–2019
Somerville, Massachusetts, US41998–2005
Sommerville, Massachusetts, US12001
Tokyo, JP11999